INGN
Inogen IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$185.18M
P/E Ratio
—
EPS
$-0.86
Beta
1.71
52W High
$9.13
52W Low
$5.34
50-Day MA
$6.07
200-Day MA
$7.05
Dividend Yield
—
Profit Margin
-6.52%
Forward P/E
—
PEG Ratio
3.48
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other physicians, and third-party payers in the United States and internationally. The company is headquartered in Goleta, California.
Fundamentals
| Revenue (TTM) | $348.67M |
| Gross Profit (TTM) | $154.26M |
| EBITDA | $-9.55M |
| Operating Margin | -12.20% |
| Return on Equity | -12.40% |
| Return on Assets | -6.35% |
| Revenue/Share (TTM) | $13.11 |
| Book Value | $7.06 |
| Price-to-Book | 0.88 |
| Price-to-Sales (TTM) | 0.53 |
| EV/Revenue | 0.192 |
| EV/EBITDA | -17.60 |
| Quarterly Earnings Growth (YoY) | 87.30% |
| Quarterly Revenue Growth (YoY) | 2.00% |
| Shares Outstanding | $27.23M |
| Float | $24.03M |
| % Insiders | 11.97% |
| % Institutions | 76.73% |
Analyst Ratings
Consensus ($12.67 target)
1
Strong Buy1
BuyData last updated: 4/8/2026